National Health (Highly specialised drugs program for hospitals) Special Arrangement Amendment Instrument 2012 (No. 11) (No. PB 110 of 2012) (Cth)
PB 110 of 2012
National Health (Highly specialised drugs program for hospitals) Special Arrangement Amendment Instrument 2012 (No. 11)
National Health Act 1953
___________________________________________________________________________
I, KIM BESSELL, Assistant Secretary, Pharmaceutical Access Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this Amendment Instrument under subsections 100(1) and 100(2) of the National Health Act 1953.
Dated 12 December 2012
KIM BESSELL
Assistant Secretary
Pharmaceutical Access Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
___________________________________________________________________________
1 Name of Instrument
(1)This Instrument is the National Health (Highly specialised drugs program for hospitals) Special Arrangement Amendment Instrument 2012 (No.11).
(2)This Instrument may also be cited as PB 110 of 2012.
2 Commencement
This Instrument commences on 1 January 2013.
3 Amendments to PB 116 of 2010
Schedule 1 amends the National Health (Highly specialised drugs program for hospitals) Special Arrangement 2010 (PB 116 of 2010).
Schedule 1 Amendments
Section 3
[1] Schedule 1, entry for Mycophenolic Acid in the form Capsule containing mycophenolate mofetil 250mg, brand Cellplant
Omit
[2] Schedule 1, entry for Mycophenolic Acid in the form Tablet containing mycophenolate mofetil 500mg, brand Cellplant
Omit
[3] Schedule 2, entry for Willow Pharmaceuticals Pty Ltd
Omit
WQ Willow Pharmaceuticals Pty Limited 80 118 534 704
Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.
See
0
0
0